Medical News

RSS

Heavy drinking now poses greater liver disease risk than two decades ago

Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, according to a new Keck Medicine of USC study published today in Clinical Gastroenterology and Hepatology.

23 Jul 2025

Weill Cornell Medicine launches study to advance treatments for rare neurological disorder

A $1.1 million grant from the parent-caregiver-led Rare Bird Foundation to Weill Cornell Medicine is supporting the launch of a natural history study for a rare neurodevelopmental disorder that causes developmental delays and seizures called MEF2C Haploinsufficiency syndrome (MCHS).

23 Jul 2025

Insights into antibiotic resistance and virulence of Bordetella hinzii

Announcing a new article publication for Zoonoses journal. This study was aimed at analyzing the pathogenic characteristics of Bordetella hinzii (B. hinzii), and elucidating its antibiotic resistance mechanisms, virulence gene distribution, and vaccine development potential.

23 Jul 2025

Novel DNA plasmid therapy shows high success rate in treating chronic pain in dogs

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain demonstrating a 90% success rate.

23 Jul 2025

New collaborative effort harnesses AI to drive ALS drug discovery in Louisiana

Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases.

23 Jul 2025

STRIDE immunotherapy sets new benchmark for survival in advanced liver cancer

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma (uHCC, an advanced liver cancer that could not be treated with surgery or other localized treatments) has shown that one in five (19.6%) participants treated with STRIDE (Single Tremelimumab Regular Interval Durvalumab) a combination of two immunotherapies, remained alive after five years of follow-up versus one in 10 (9.4%) participants treated with sorafenib, a standard treatment for uHCC when the study was designed.

23 Jul 2025

Oral microbiome changes explain blood pressure reduction from beetroot juice

The blood pressure lowering effect of nitrate-rich beetroot juice in older people may be due to specific changes in their oral microbiome, according to the largest study of its kind.

23 Jul 2025

EU initiative puts nutrition at the heart of diabetes care

Managing type 2 diabetes isn't just about medicine—it's also about what's on your plate. Cook2DIAbeat is a new EU-supported initiative that puts food front and centre in the fight against diabetes.

23 Jul 2025

Temporary tattoo sticker could detect small amounts of GHB in alcoholic beverages

Temporary tattoos aren't just for kids anymore - semi-permanent versions have become a favorite among adults who don't want the commitment of the real thing.

23 Jul 2025

New project aims to boost screening for cardiovascular disease marker in community health centers

Elevated lipoprotein(a), also known as Lp(a), is an independent, inherited and causal risk factor for cardiovascular disease, the leading cause of death and disability worldwide.

23 Jul 2025

Indian pharma group relies on high-tech solutions from L.B. Bohle

Investing in L.B. Bohle's innovative technologies, the Indian pharmaceutical company optimizes processes and strengthens its competitive edge in the market.

From L.B. Bohle Maschinen und Verfahren GmbH 23 Jul 2025

Intranasal insulin safely and effectively reaches key memory regions of the brain

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal spray, safely and effectively reaches key memory regions of the brain in older adults.

23 Jul 2025

New diagnostic test identifies head and neck cancer patients curable by surgery alone

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for radiation or chemotherapy.

23 Jul 2025

Long-term air pollution exposure triggers allergic immune responses in the lungs

Air pollution is a global health concern, with over 90% of the world's population breathing air that exceeds World Health Organization safety standards.

23 Jul 2025

Everyday diet ingredients like caffeine can affect bacterial antibiotic resistance

Ingredients of our daily diet - including caffeine - can influence the resistance of bacteria to antibiotics. This has been shown in a new study by a team of researchers at the Universities of Tübingen and Würzburg led by Professor Ana Rita Brochado.

23 Jul 2025

Substance use disorders increase risk of unplanned hospital readmissions

People with any type of substance use disorder (SUD) stand a 24% higher risk of having an unplanned hospital readmission within 30 days of a previous discharge compared with those without the disorder, new UCLA-led research finds.

23 Jul 2025

Liupao tea improves metabolic syndrome risks in clinical trial

Liupao tea shows promise in improving metabolic syndrome markers, enhancing heart health and gut balance in just three months, according to recent research.

23 Jul 2025

RSV causes severe outcomes and heart complications in older adults

Respiratory syncytial virus (RSV) is a well-known cause of infections in children, but it's understudied in older individuals.

23 Jul 2025

New therapeutic approach targets undruggable protein driving aggressive breast cancer

In a major stride toward tackling aggressive breast cancer, researchers from The Hebrew University of Jerusalem have developed druglike molecules that degrade a previously "undruggable" cancer-driving protein.

23 Jul 2025

Machine learning improves prediction of death risk in hospitalized cirrhosis patients

Researchers employed a machine learning technique known as random forest analysis and found that it significantly outperformed traditional methods in predicting which hospitalized patients with cirrhosis are at risk of death, according to a new paper published in Gastroenterology.

23 Jul 2025

Medical News

Heavy drinking now poses greater liver disease risk than two decades ago

Weill Cornell Medicine launches study to advance treatments for rare neurological disorder

Insights into antibiotic resistance and virulence of Bordetella hinzii

Novel DNA plasmid therapy shows high success rate in treating chronic pain in dogs

New collaborative effort harnesses AI to drive ALS drug discovery in Louisiana

STRIDE immunotherapy sets new benchmark for survival in advanced liver cancer

Oral microbiome changes explain blood pressure reduction from beetroot juice

EU initiative puts nutrition at the heart of diabetes care

Temporary tattoo sticker could detect small amounts of GHB in alcoholic beverages

New project aims to boost screening for cardiovascular disease marker in community health centers

Indian pharma group relies on high-tech solutions from L.B. Bohle

Intranasal insulin safely and effectively reaches key memory regions of the brain

New diagnostic test identifies head and neck cancer patients curable by surgery alone

Long-term air pollution exposure triggers allergic immune responses in the lungs

Everyday diet ingredients like caffeine can affect bacterial antibiotic resistance

Substance use disorders increase risk of unplanned hospital readmissions

Liupao tea improves metabolic syndrome risks in clinical trial

RSV causes severe outcomes and heart complications in older adults

New therapeutic approach targets undruggable protein driving aggressive breast cancer

Machine learning improves prediction of death risk in hospitalized cirrhosis patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News